Bank of America drops shocking price target on hot weight-loss stock post-earnings
Hims & Hers Health (HIMS) has been arguably the biggest beneficiary of the weight-loss drug wave, posting record sales and backed by a booming subscriber base. However, not everyone’s buying…
Share